Related Experiment Video
Updated: May 8, 2026
08:03
In Vitro Model of Coronary Angiogenesis
Published on: March 10, 2020
Cardiac angiogenesis directed by stable Hypoxia Inducible Factor-1
Chad B Walton1, Jennifer Ecker, Cynthia D Anderson
1Department of Medicine, University of Hawaii, Honolulu, HI 96813, USA. cwalton@hawaii.edu.
Vascular Cell
|August 31, 2013
Summary
This study shows how Hypoxia Inducible Factor-1 (HIF-1) drives new blood vessel growth in the heart. Manipulating HIF signaling can improve blood flow and treat conditions like ischemia.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Medical Research
Background:
- Hypoxia Inducible Factor-1 (HIF-1) is an oxygen-sensitive transcription factor crucial for angiogenesis.
- HIF-1 plays a significant role in the body's response to ischemia and cancer development.
Purpose of the Study:
- To investigate the structural characteristics of HIF-directed angiogenesis.
- To evaluate the therapeutic potential of manipulating HIF signaling for enhanced perfusion and ischemia treatment.
Main Methods:
- Developed a transgenic mouse model with a tetracycline-inducible, oxygen-stable HIF-1α construct.
- Induced HIF-1α expression in adult mouse hearts for up to 28 days.
- Utilized ultrasound contrast analysis, corrosion casts with scanning electron microscopy, and immunohistochemistry.
Main Results:
- Induced angiogenesis and progressive ventricular dysfunction in mouse hearts.
- Observed increased myocardial red cell volume and formation of capillary 'lakes'.
- Confirmed progressive functional neovascularization via pro-angiogenic factors DLL-4, Notch-1, and PDGF-β.
Conclusions:
- Demonstrated the structural details of HIF-mediated angiogenesis.
- Supported the use of HIF signaling manipulation to improve cardiac perfusion.
- Highlighted potential therapeutic strategies for ischemic conditions.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...